View Agent
| Agent Info | |
| Agent: | LY2157299 |
| Synonyms: | NA |
| Drug Status For Certain Diseases: | NA |
| Classification: | a serine/threonine kinase inhibitor that blocks specifically the TGFβRI kinase |
| Target: | TGF-beta receptor type I |
| KEGG Pathway: | Hepatitis B MAPK signaling pathway TGF-beta signaling pathway Pancreatic cancer Colorectal cancer HTLV-I infection Adherens junction Endocytosis Cytokine-cytokine receptor interaction Pathways in cancer Chronic myeloid leukemia Chagas disease (American trypanosomiasis) Hippo signaling pathway FoxO signaling pathway Osteoclast differentiation |
| Wiki Pathway: | Integrated Breast Cancer Pathway Extracellular vesicle-mediated signaling in recipient cells TGF beta Signaling Pathway Integrated Pancreatic Cancer Pathway Signaling by TGF-beta Receptor Complex MAPK Signaling Pathway p38 MAPK Signaling Pathway Cardiac Hypertrophic Response TGF Beta Signaling Pathway |